Dr. Margolis said this clinical trial demonstrates the strength of collaboration among Ϲ, Children's Wisconsin, Froedtert Hospital and the entire community. A separate pediatric clinical trial for CAR-T treatment is planned for later this year at Children's Wisconsin in the MACC Fund Center.
Dr. Bryon Johnson explained the CAR-T cell immunotherapy as "a search-and-destroy mission," in which the patient’s existing immune cells are modified to attack cancer cells.